Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

University of Guelph

$25,000.00

Aptasensor construction for detection of environmental pathogens and contaminants

EF 2015-16

Résumé
Environmental Bio-Detection Products Inc. (EBPI) is a Canadian biotechnology company located in Mississauga, Ontario, which specializes in the development of biological testing kits for detection of bacterial contamination in water and assessment of toxicity from chemical pollution in environmental samples. In this NSERC Engage application, EBPI, with the cooperation of Dr. Manderville's laboratory at the University of Guelph, will develop a DNA-based fluorescent detection device for cyanobacteria contamination of water. Microcystins (MCs) are a class of cyanobacterial hepatoxins that are environmental and human health hazards. A single-strand of DNA (aptamer) has been developed that binds specifically to the most abundant and toxic MC congener (referred to MC-LR) with a binding affinity in the 50 nanomolar range (detection aptamer called AN6). The goal of this project is to convert AN6 into a fluorescent device (aptasensor) that can detect MC-LR in water samples at or below the regulatory guidelines of the world health organization (WHO) tolerable daily intake (0.5 ug/L). Two aptasensor platforms are proposed that will be applied to AN6 in order to achieve a detectable fluorescent signal when MC-LR binds to AN6. The results of these studies will be implemented in a proof-of-concept device to demonstrate functionality. EBPI with Dr. Manderville's laboratory will then embark on the development of a commercially available product line for MC-LR detection in water samples of varying chemistry.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
478770-2015
Name nom
Manderville, Richard
Department département
Chemistry
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
400
Area of application group en
Environment
Area of application group fr
Environnement
Area of application en
Environment
Area of application fr
Environnement
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Bioanalytical chemistry
Research subject fr
Chimie bioanalytique
Partie
1
Nb partie
1
Application title
Aptasensor construction for detection of environmental pathogens and contaminants
Keyword
NSERC
Application summary
Environmental Bio-Detection Products Inc. (EBPI) is a Canadian biotechnology company located in Mississauga, Ontario, which specializes in the development of biological testing kits for detection of bacterial contamination in water and assessment of toxicity from chemical pollution in environmental samples. In this NSERC Engage application, EBPI, with the cooperation of Dr. Manderville's laboratory at the University of Guelph, will develop a DNA-based fluorescent detection device for cyanobacteria contamination of water. Microcystins (MCs) are a class of cyanobacterial hepatoxins that are environmental and human health hazards. A single-strand of DNA (aptamer) has been developed that binds specifically to the most abundant and toxic MC congener (referred to MC-LR) with a binding affinity in the 50 nanomolar range (detection aptamer called AN6). The goal of this project is to convert AN6 into a fluorescent device (aptasensor) that can detect MC-LR in water samples at or below the regulatory guidelines of the world health organization (WHO) tolerable daily intake (0.5 ug/L). Two aptasensor platforms are proposed that will be applied to AN6 in order to achieve a detectable fluorescent signal when MC-LR binds to AN6. The results of these studies will be implemented in a proof-of-concept device to demonstrate functionality. EBPI with Dr. Manderville's laboratory will then embark on the development of a commercially available product line for MC-LR detection in water samples of varying chemistry.